Today: 21 May 2026
CleanSpark (CLSK) Upsizes $1.15B Zero‑Coupon Convertible; Shares Dip as Funds Target Power, AI Data Centers & $460M Buyback (Nov. 11, 2025)
11 November 2025
2 mins read

CleanSpark (CLSK) Upsizes $1.15B Zero‑Coupon Convertible; Shares Dip as Funds Target Power, AI Data Centers & $460M Buyback (Nov. 11, 2025)

  • CleanSpark priced and upsized a private $1.15 billion 0.00% Convertible Senior Notes offering due February 15, 2032, lifting the deal after strong demand. Initial conversion price:$19.16 (a 27.5% premium to Monday’s $15.03 close). Optional add‑on: up to $150M more within 13 days. Expected close:Nov. 13, 2025.
  • The company plans to repurchase ~$460M of common stock from note investors at $15.03 per share, and allocate the rest of the net $1.13B to power & land expansion, data center build‑outs, and repayment of bitcoin‑backed credit lines.
  • Market reaction: CLSK fell ~5% pre‑market to around $14, as convertible deals often trigger short‑term pressure from hedging.
  • Context: CleanSpark produced 612 BTC in October, ended the month with ~13,033 BTC on the balance sheet, and recently entered Texas with a 285‑MW power footprint for AI/HPC.

What happened today

CleanSpark, Inc. (Nasdaq: CLSK) upsized and priced a private offering of $1.15 billion in 0% convertible senior notes due 2032. The terms set an initial conversion rate of 52.1832 shares per $1,000 of notes, equating to an initial conversion price of $19.16—a 27.5% premium to Monday’s close. The company may increase the offering by $150 million if initial purchasers exercise a 13‑day option. The deal is slated to close on Nov. 13, subject to customary conditions.

CleanSpark will use about $460 million of the proceeds to repurchase common stock from certain note investors at $15.03 per share, with the remaining net proceeds (~$1.13B) earmarked for expanding its power and land portfolio, developing data‑center infrastructure, repaying bitcoin‑backed credit balances, and general corporate purposes.

How the market is reading it

CLSK shares traded lower pre‑market—about 5%—after the upsizing, a move CoinDesk attributed in part to typical delta‑hedging dynamics around convertibles. As of publication, CLSK is trading intraday near $14.

The broader context across bitcoin miners: convertible issuance has surged in 2025 as operators fund power contracts and AI/HPC expansions while hashprice tightens. Independent industry outlet TheMinerMag framed CleanSpark’s upsizing as part of a record wave of miner debt supporting AI‑aligned compute buildouts.

Why it matters

CleanSpark is positioning itself beyond pure bitcoin mining to capture high‑performance computing (HPC) and AI demand, a shift underpinned by recent Texas power and land acquisitions (285 MW) and a rising contracted‑power base. The October operations update612 BTC mined and ~13,033 BTC held—illustrates continued production while the company reallocates capital toward compute infrastructure near key metros.

The fine print (deal terms you should know)

  • Coupon:0.00%; senior unsecured.
  • Maturity:Feb. 15, 2032; no redemption before Feb. 20, 2029; redeemable thereafter if price conditions are met.
  • Settlement: At the company’s election in cash, shares, or a mix.
  • Early convertibility: Restricted until Aug. 15, 2031, then open until shortly before maturity.
    All above per the company’s pricing release.

By the numbers — quick math on dilution & buybacks

These are illustrative calculations based on today’s disclosed terms and recent share counts; actual outcomes depend on settlement choices and future events.

  • Implied shares if fully converted at the initial rate:
    $1.15B ÷ $1,000 × 52.183260.0M shares (and ~7.83M more if the $150M option is fully exercised).
  • Context vs. shares outstanding: CleanSpark reported ~281M basic shares around its June‑quarter report; on that base, 60.0M would equal ~21% potential dilution (~24% including the option)—if the notes were ultimately settled entirely in stock at the initial rate. The company can instead settle in cash or a mix, which could materially change the actual dilution.
  • Repurchase math:$460M at $15.03 implies roughly 30.6M shares to be repurchased from note investors in concurrent, privately negotiated transactions—helping offset near‑term float and hedging pressure linked to the convertible. (Final share count may vary.)

What to watch next

  • Closing of the deal (target: Nov. 13) and any subsequent 8‑K detailing final terms and settlement mechanics.
  • Capital deployment cadence into power contracts, land, and data‑center development—particularly in Texas—as CleanSpark scales for AI/HPC alongside bitcoin mining.
  • Operational momentum: After October’s 612 BTC and reported capacity additions, investors will track production, hashrate, and treasury levels into the seasonally stronger winter months.
  • Stock dynamics: Additional volatility is common around convertible offerings as banks and investors hedge and rebalance positions.

Disclosure: This article is for information only and not investment advice. All figures are based on company disclosures and reputable media reporting as cited.

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025
Previous Story

Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook
Next Story

Pfizer (PFE) Today — Nov. 11, 2025: $10B Metsera Deal Nears Vote, Oncology Game Plan Expands, Shares Rise

Go toTop